Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1374570 | Bioorganic & Medicinal Chemistry Letters | 2010 | 6 Pages |
Abstract
Modifying FTY720, an immunosuppressant modulator, led to a new series of well phosphorylated tetralin analogs as potent S1P1 receptor agonists. The stereochemistry effect of tetralin ring was probed, and (−)-(R)-2-amino-2-((S)-6-octyl-1,2,3,4-tetrahydronaphthalen-2-yl)propan-1-ol was identified as a good SphK2 substrate and potent S1P1 agonist with good oral bioavailability.
Graphical abstractThe synthesis, characterization and stereochemistry activity relationship of tetralin S1P agonist prodrugs is reported. (2R,2′S)-5 (ED50 = 0.1 mg/kg) was identified as a good SphK2 substrate and potent S1P1 agonist with good oral bioavailability.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Bin Ma, Kevin M. Guckian, Edward Yin-Shiang Lin, Wen-Cherng Lee, Daniel Scott, Gnanasambandam Kumaravel, Timothy L. Macdonald, Kevin R. Lynch, Cheryl Black, Sowmya Chollate, Kyungmin Hahm, Gregg Hetu, Ping Jin, Yi Luo, Ellen Rohde, Anthony Rossomando,